SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001346302-20-000070
Filing Date
2020-11-09
Accepted
2020-11-09 16:01:45
Documents
64
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q xers-20200930.htm   iXBRL 10-Q 1747615
2 EX-10.1 exh101firstamendmentto.htm EX-10.1 15883
3 EX-10.2 exh102thirdamendmentto.htm EX-10.2 33637
4 EX-31.1 q32020exhibit311.htm EX-31.1 10878
5 EX-31.2 q32020exhibit312.htm EX-31.2 10825
6 EX-32.1 q32020exhibit321.htm EX-32.1 7529
  Complete submission text file 0001346302-20-000070.txt   6687020

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xers-20200930.xsd EX-101.SCH 41801
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xers-20200930_cal.xml EX-101.CAL 36422
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xers-20200930_def.xml EX-101.DEF 286452
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xers-20200930_lab.xml EX-101.LAB 553905
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xers-20200930_pre.xml EX-101.PRE 378719
12 EXTRACTED XBRL INSTANCE DOCUMENT xers-20200930_htm.xml XML 943264
Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Filer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38536 | Film No.: 201297622
SIC: 2834 Pharmaceutical Preparations